Atlas Trials

Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

Clinical trial NCT00842894 · COMPLETED

Trial details

NCT number
NCT00842894
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2009-05-01
Primary completion
2010-10-01
Enrollment
3421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.